UB Paderborn / Katalog / Suche / in CDI

Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA

Science (American Association for the Advancement of Science), 2014-03, Vol.343 (6176), p.1221-1228

2014

Link zum Volltext

Verfügbarkeit prüfen

Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins

PLoS pathogens, 2021-12, Vol.17 (12), p.e1010118-e1010118

2021

Link zum Volltext

Verfügbarkeit prüfen

Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use

PloS one, 2017-08, Vol.12 (8), p.e0182936-e0182936

2017

Link zum Volltext

Verfügbarkeit prüfen

Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins

PLoS pathogens, 2022-02, Vol.18 (2), p.e1010289-e1010289

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B

BMC health services research, 2021-08, Vol.21 (1), p.1-846, Article 846

2021

Link zum Volltext

Verfügbarkeit prüfen

Entamoeba histolytica‐associated proctitis and ileitis mimicking Crohn's disease—A case report

Clinical case reports, 2023-05, Vol.11 (5), p.e6833-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study

PeerJ (San Francisco, CA), 2023-09, Vol.11, p.e16072-e16072, Article e16072

2023

Link zum Volltext

Verfügbarkeit prüfen

Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study

Journal of cachexia, sarcopenia and muscle, 2022-02, Vol.13 (1), p.169-179

2022

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany

Annals of hepatology, 2022-09, Vol.27 (5), p.100719-100719, Article 100719

2022

Link zum Volltext

Verfügbarkeit prüfen

Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo

Journal of hepatology, 2011-12, Vol.55 (6), p.1272-1280

2011

Link zum Volltext

Verfügbarkeit prüfen

Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma

Liver cancer (Basel ), 2019-10, Vol.8 (5), p.387-402

2019

Link zum Volltext

Verfügbarkeit prüfen

Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C Patients

Cells (Basel, Switzerland), 2021-03, Vol.10 (4), p.774

2021

Link zum Volltext

Verfügbarkeit prüfen

Current progress in immunotherapy of hepatocellular carcinoma

Journal of hepatology, 2017-03, Vol.66 (3), p.482-484

2017

Link zum Volltext

Verfügbarkeit prüfen

Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients

World journal of gastroenterology : WJG, 2009-01, Vol.15 (4), p.449-456

2009

Link zum Volltext

Verfügbarkeit prüfen

No Evidence for Classic Thrombotic Microangiopathy in COVID-19

Journal of clinical medicine, 2021-02, Vol.10 (4), p.671

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune control in hepatocellular carcinoma development and progression: role of stromal cells

Seminars in liver disease, 2014-11, Vol.34 (4), p.376

2014

Link zum Volltext

Verfügbarkeit prüfen

Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19

Journal of thrombosis and haemostasis, 2021-09, Vol.19 (9), p.2335-2347

2021

Link zum Volltext

Verfügbarkeit prüfen

T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice

Gastroenterology (New York, N.Y. 1943), 2015-10, Vol.149 (4), p.1042-1052

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection

Journal of investigative medicine, 2020-08, Vol.68 (6), p.1199-1202

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission

Medical microbiology and immunology, 2021-06, Vol.210 (2-3), p.165-171

2021

Link zum Volltext

Verfügbarkeit prüfen

Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function

International journal of cardiology, 2018-11, Vol.271, p.296-300

2018

Link zum Volltext

Verfügbarkeit prüfen

Facing the dawn of immunotherapy for hepatocellular carcinoma

Journal of hepatology, 2013-07, Vol.59 (1), p.9-10

2013

Link zum Volltext

Verfügbarkeit prüfen

Response: Frailty assessment in the COVID-19 pandemic

Journal of investigative medicine, 2020-10, Vol.68 (7), p.1302-1302

2020

Link zum Volltext

Verfügbarkeit prüfen

Patterns of liver injury in COVID-19 – a German case series

United European gastroenterology journal, 2020-08, Vol.8 (7), p.814-819

2020

Link zum Volltext

Verfügbarkeit prüfen

Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir

Digestive and liver disease, 2016-03, Vol.48 (3), p.291-297

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA

Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins

Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use

Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins

Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B

Entamoeba histolytica‐associated proctitis and ileitis mimicking Crohn's disease—A case report

Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study

Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study

Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany

Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo

Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma

Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C Patients

Current progress in immunotherapy of hepatocellular carcinoma

Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients

No Evidence for Classic Thrombotic Microangiopathy in COVID-19

Immune control in hepatocellular carcinoma development and progression: role of stromal cells

Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19

T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice

Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection

Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission

Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function

Facing the dawn of immunotherapy for hepatocellular carcinoma

Response: Frailty assessment in the COVID-19 pandemic

Patterns of liver injury in COVID-19 – a German case series

Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir

Suchergebnisse filtern